As the pharmaceutical developers transition from blockbuster APIs to niche busters, they are facing new challenges with formulating poorly absorbable APIs. This webcast will provide a brief overview of the market dynamics and discuss in detail possible oral dosage form solutions to help overcome challenges with bioavailability and absorption of complex drug formulations. Key Learning Objectives:
  • Provide a better understanding of lipid-based formulations and how they help improve bioavailability.
  • Discuss amorphous solid dispersions and how it can improve absorption.
  • Review possible oral dosage form solutions and tips on how to choose the right capsule to meet development requirements.
Who Should Watch: Research and development scientists, formulation scientists
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest CHI content
Latest briefing from the Knowledge Center